4-carbobenzyloxy-1-(2-nitrophenyl)-piperazine-2-carboxylic acid | 64173-00-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-carbobenzyloxy-1-(2-nitrophenyl)-piperazine-2-carboxylic acid
• 英文别名: 4-carbobenzoxy-1-(o-nitrophenyl)piperazine-2-carboxylic acid；4-[(benzyloxy)carbonyl]-1-(2-nitrophenyl)-2-piperazinecarboxylic acid；4-carbobenzyloxy-1-(2-nitrophenyl) piperazine-2-carboxylic acid；1-(2-nitrophenyl)-4-phenylmethoxycarbonylpiperazine-2-carboxylic acid
• CAS: 64173-00-8
• 化学式: C₁₉H₁₉N₃O₆
• 分子量: 385.376
• InChiKey: BQLURULOTFVALG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  116
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  4-carbobenzyloxy-1-(2-nitrophenyl)-piperazine-2-carboxylic acid 在 铁粉 、 sodium hydride 、 溶剂黄146 作用下， 生成 Benzyl 6-methyl-5-oxo-1,2,4,4a-tetrahydropyrazino[1,2-a]quinoxaline-3-carboxylate
  参考文献：
  名称：

  Synthesis and 5-Hydroxytryptamine (5-HT) activity of 2,3,4,4a-Tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-Hexahydro-1H-pyrazino[1,2-a]quinoxalines

  摘要：

  A series of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]-quinoxalines was shown to exhibit 5-HT2C agonist binding and Functional activity. Compound 21R inhibited food intake over 2 h in fasted, male Sprague-Dawley rats with ED50 values of 2 mg/kg (ip) and 10 mg/kg (po). (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00400-5
• 作为产物：
  描述：

  氯甲酸苄酯 在 sodium hydroxide 、 乙二胺四乙酸 、 sodium carbonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 75.0h， 生成 4-carbobenzyloxy-1-(2-nitrophenyl)-piperazine-2-carboxylic acid
  参考文献：
  名称：

  Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them

  摘要：

  式(I)的化合物： 其中 A代表一个5、6或7-成员的(杂)芳香族或非芳香族环， n和n′代表0、1或2 X代表描述中定义的烷基链， R3代表芳基或杂芳基团， R1和R2中的一个代表氢原子，另一个代表描述中定义的式(II)的团。 含有这些化合物的药物，对治疗涉及凋亡缺陷的疾病有用。

  公开号：

  US20080188460A1

文献信息

• 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and
  申请人：American Home Products Corporation

  公开号：US04032639A1

  公开（公告）日：1977-06-28

  Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals.

  该化合物的分子式为##STR1##其中R为氢（较低）烷基，苯（较低）烷基，苯甲酰（较低）烷基或对-卤苯甲酰（较低）烷基；R.sup.1为氢或（较低）烷基；R.sup.2为氢，（较低）烷基，（较低）甲氧基，氯，氟，三氟甲基或氨基，位于7、8或9位置；R.sup.3为氢或（较低）烷基；R.sup.4为氢，（较低）烷基，（较低）甲氧基，氯，氟或三氟甲基，位于7、8或9位置；或其无毒酸加合物盐；对高血压动物产生降压作用。
• Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands
  申请人：——

  公开号：US20020177596A1

  公开（公告）日：2002-11-28

  The present invention is directed to novel compounds represented by structural Formulas (I) and (I-a): 1 or a pharmaceutically acceptable salt thereof, wherein R 1 , R 4a , R 4b , R 5 , R 6 , R 7 , R 8 , R 9 , n, and X are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep and sexual disorders, migraine and other conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.

  本发明涉及由结构式（I）和（I-a）表示的新化合物：1或其药学上可接受的盐，其中R1、R4a、R4b、R5、R6、R7、R8、R9、n和X在此处描述。本发明还涉及包含这些新化合物作为活性成分的药物配方，以及利用这些新化合物及其配方治疗某些疾病。本发明的化合物是5-羟色胺激动剂和拮抗剂，可用于控制或预防包括肥胖、焦虑、抑郁、精神病、精神分裂症、睡眠和性功能障碍、偏头痛以及与头痛相关的其他情况、社交恐惧症和胃肠道疾病（如胃肠道运动功能障碍）等中枢神经系统疾病。
• 4-Carbobenzoxypiperazine-2-carboxylic acid chemical intermediate
  申请人：American Home Products Corporation

  公开号：US04182869A1

  公开（公告）日：1980-01-08

  Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals. Also disclosed are chemical intermediates including 4-carbobenzoxypiperazine-2-carboxylic acid.

  该配方的化合物##STR1##其中R为氢（较低）烷基，苯（较低）烷基，苯甲酰（较低）烷基或对卤苯甲酰（较低）烷基; R.sup.1为氢或（较低）烷基; R.sup.2为氢，（较低）烷基，（较低）烷氧基，氯，氟，三氟甲基或7-，8-或9-位的氨基; R.sup.3为氢或（较低）烷基; R.sup.4为氢，（较低）烷基，（较低）烷氧基，氯，氟或三氟甲基，位于7-，8-或9-位; 或其无毒酸盐; 对高血压动物具有降压作用。还公开了包括4-羧基苯甲酰基哌嗪-2-羧酸在内的化学中间体。
• 4-(Lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acid chemical
  申请人：American Home Products Corporation

  公开号：US04182872A1

  公开（公告）日：1980-01-08

  Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals. Also disclosed are chemical intermediates, including 4-(lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acids.

  化合物的化学式为##STR1##其中R为氢（低）烷基，苯（低）烷基，苯甲酰（低）烷基或对卤苯甲酰（低）烷基；R.sup.1为氢或（低）烷基；R.sup.2为氢，（低）烷基，（低）烷氧基，氯，氟，三氟甲基或7-，8-或9-位上的氨基；R.sup.3为氢或（低）烷基；R.sup.4为氢，（低）烷基，（低）烷氧基，氯，氟或三氟甲基或7-，8-或9-位上的氨基；或其无毒酸盐。这些化合物对高血压动物具有降压作用。还披露了化学中间体，包括4-（低）烷基-1-（o-硝基苯基）哌嗪-2-羧酸。
• 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2]quinoxalin-5(6)-ones and derivatives
  申请人：American Home Products Corporation

  公开号：US04089958A1

  公开（公告）日：1978-05-16

  Compounds of the formula ##STR1## WHEREIN R is hydrogen (lower)alkyl, phen(lower)-alkyl, benzoyl(lower)alkyl, or p-halobenzoyl-(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)-alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hyptotensive effect in hypertensive animals.

  该化合物的公式为##STR1## 其中R为氢（低）烷基，苯（低）烷基，苯甲酰（低）烷基或对卤苯甲酰（低）烷基；R.sup.1为氢或（低）烷基；R.sup.2为氢，（低）烷基，（低）烷氧基，氯，氟，三氟甲基或7-，8-或9-位的氨基；R.sup.3为氢或（低）烷基；R.sup.4为氢，（低）烷基，（低）烷氧基，氯，氟或三氟甲基或7-，8-或9-位；或其无毒酸加成盐；对高血压动物具有降血压作用。